Dhungel Omkar, Shrestha Amit, Sharma Pawan, Sapkota Nidesh, Paudel Raju
Department of Psychiatry, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal.
Department of Neurology, Grande International Hospital, Tokha, Kathmandu, Nepal.
Case Rep Neurol Med. 2024 Mar 31;2024:8154006. doi: 10.1155/2024/8154006. eCollection 2024.
Segawa syndrome usually manifests as dystonia, disturbance of gait with fatigue, and may be confused with spasticity. Also known as dopamine-responsive dystonia (DRD), it should be considered in any child who presents with paroxysmal or progressive hypertonia of unknown etiology, which responds dramatically to levodopa. It is a clinical diagnosis, but the level of pterins in cerebrospinal fluid and guanosine triphosphate cyclohydrolase-1 (GTCH 1) gene mutation testing done by molecular genetic testing are confirmatory. Our case is a 45-year female with a family history of similar illness expressed as autosomal recessive inheritance pattern. She had symptoms onset at an early age of 13 years with features of dystonia of predominantly lower limbs, hence the inability to maintain posture and walk. Dramatic improvement with levodopa but sudden deterioration to dystonia due to noncompliance was evident in our patient with troublesome features of concomitant adjustment disorder during presentation.
Segawa综合征通常表现为肌张力障碍、步态紊乱伴疲劳,可能与痉挛相混淆。它也被称为多巴胺反应性肌张力障碍(DRD),对于任何出现病因不明的阵发性或进行性张力亢进且对左旋多巴有显著反应的儿童都应考虑该病。这是一种临床诊断,但通过分子基因检测测定脑脊液中的蝶呤水平和鸟苷三磷酸环化水解酶-1(GTCH 1)基因突变检测具有确诊意义。我们的病例是一名45岁女性,有类似疾病的家族史,呈常染色体隐性遗传模式。她在13岁时发病,主要表现为下肢肌张力障碍,因此无法维持姿势和行走。左旋多巴治疗效果显著,但我们的患者因不遵医嘱突然恶化为肌张力障碍,就诊时伴有令人困扰的适应障碍特征。